Map Medical: Intends to acquire no less than 51% of the equity of Yi Jie Medical, stock trading suspended.

Map Medical announced that the company is planning to issue shares and pay cash to purchase assets and raise matching funds, which is expected to constitute a major asset restructuring and related party transactions, but not a restructuring listing. The company's securities will be suspended from trading starting from May 22, 2025, and the transaction plan is expected to be disclosed within no more than 10 trading days. The target asset is a stake of not less than 51% in Guangzhou Yijie Medical Technology Co., Ltd., with main counterparties including Guangzhou Zexin Medical Technology Co., Ltd. The company has signed a letter of intent with the main counterparties, but the specific transaction method and plan will be subject to the information disclosed in the subsequent restructuring plan or restructuring report.